Lucas Svetlana 4
4 · aTYR PHARMA INC · Filed Jul 2, 2019
Insider Transaction Report
Form 4
aTYR PHARMA INCLIFE
Lucas Svetlana
Director
Transactions
- Award
Stock Option (right to buy)
2019-06-28+2,285→ 2,285 totalExercise: $5.13Exp: 2029-06-28→ Common Stock (2,285 underlying)
Footnotes (2)
- [F1]The shares subject to this option shall vest and become exercisable in 36 equal monthly installments beginning July 28, 2019, such that this option will be fully exercisable on June 28, 2022, subject to the recipient's continued service on the Issuer's Board of Directors.
- [F2]The shares of Common Stock reported herein give effect to the 1-for-14 reverse stock split which became effective in accordance with the terms of the Certificate of Amendment to the Company's Restated Certificate of Incorporation filed with the Secretary of State of Delaware on June 28, 2019.